Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017 Jul;11(4):317-370. doi: 10.1007/s12072-017-9799-9. Epub 2017 Jun 15. PMID: 28620797; PMCID: PMC5491694.
Ikeda M, Kudo M, Aikata H, Nagamatsu H, Ishii H, Yokosuka O, Torimura T, Morimoto M, Ikeda K, Kumada H, Sato T, Kawai I, Yamashita T, Horio H, Okusaka T; Miriplatin TACE Study Group. Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial. J Gastroenterol. 2018 Feb;53(2):281-290. doi: 10.1007/s00535-017-1374-6. Epub 2017 Aug 1. PMID: 28766016; PMCID: PMC5846877.
Tomishima K, Sai JK, Kanazawa R, Miura H, Shimizu R, Sato K, Ishii S, Saito H, Ito T, Fukumura Y, Shiina S, Watanabe S. Impact of MUC1 Expression on the Progression of Intraductal Papillary Mucinous Neoplasm With Worrisome Features During Follow-up. Pancreas. 2017 Oct;46(9):1127-1132. doi: 10.1097/MPA.0000000000000902. PMID: 28902782.
Nakano M, Niizeki T, Nagamatsu H, Tanaka M, Kuromatsu R, Satani M, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Koga H, Torimura T; Kurume Liver Cancer Study Group of Japan. Clinical effects and safety of intra-arterial infusion therapy of cisplatin suspension in lipiodol combined with 5-fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra-hepatic spread: A prospective cohort study. Mol Clin Oncol. 2017 Dec;7(6):1013-1020. doi: 10.3892/mco.2017.1442. Epub 2017 Oct 4. PMID: 29285366; PMCID: PMC5740831.
Shinohara K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Shimoyama Y, Shiina S, Tateishi R, Arano T, Nagino M. Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor. Surg Case Rep. 2017 Dec 2;3(1):120. doi: 10.1186/s40792-017-0391-2. PMID: 29198012; PMCID: PMC5712293.
国際学会発表
Shiina S. Radiofrequency ablation (RFA) for HCC: over 10-year outcomes and training programs. EWALT (Eastern & Western Association Liver Tumors) 2017, Sendai, Japan, 2017/1/27
Takawa M, Hayase S, Kumamoto K, Koji K, Kono K, Akasu T, Moriya Y. Outcomes of preoperative chemoradiotherapy for rectal cancer with lateral pelvic lymph node metastasis. ECCO (European Cancer Congress) 2017, Amsterdam, Netherlands, 2017/1/28
Sato K, Taniki N, Shimizu R, Hayashi M, Kanazawa R, Ishii S, Hatanaka T, Sai JK, Watanabe S, Shiina S. Factors for respiratory depression and severe body movement during percutaneous radiofrequency ablation under deep sedation. APASL (Asian-Pacific Association for the Study of the Liver) 2017, Shanghai, China, 2017/2/16
Shiina S. Radiofrequency Ablation training program for liver tumors, APASL (Asian-Pacific Association for the Study of the Liver) 2017, Shanghai, China, 2017/2/15-19
Shiina S. Usefulness of Radiofrequency Ablation Training Program for Liver Tumors. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) Nagasaki 2017, Nagasaki, Japan, 2017/4/10
Nagamatsu H. Conversion therapy with hepatic arterial infusion chemotherapy for long-term prognosis in patients with advanced hepatocellular carcinoma involving vascular invasion. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) Nagasaki 2017, Nagasaki, Japan, 2017/4/10
Takawa M, Sato K, Kanazawa R, Ishii S, Hatanaka T, Taniki N, Shimizu M, Nagamatsu H, Imai Y, Shiina S. Interventional Oncology (IVO) Suite at Juntendo University, New RFA treatment room. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) Nagasaki 2017, Nagasaki, Japan, 2017/4/10
Takawa M. Interventional Oncology (IVO) Suite at Juntendo University, New RFA Treatment Room. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) Nagasaki 2017, Nagasaki, Japan, 2017/4/10
Shimizu M. Efficacy of Tolvaptan for Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) Nagasaki 2017, Nagasaki, Japan, 2017/4/10
Sato K, Taniki N, Shimizu R, Hayashi M, Kanazawa R, Ishii S, Hatanaka T, Sai JK, Watanabe S, Shiina S. Analysis of factors for respiratory depression and severe body movement in radiofrequency ablation under deep sedation. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) Nagasaki 2017, Nagasaki, Japan, 2017/4/10
Shiina S. Radiofrequency Ablation. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) Nagasaki 2017, Nagasaki, Japan, 2017/4/11
Shiina S. Solitary HCC 2-5 cm: Resection vs. RFA?. A-PHPBA (6th Biennial Congress of The Asian-Pacific Hepato-Pancreato-Biliary Association) 2017, Yokohama, Japan, 2017/6/10
Shiina S. Radiofrequency ablation: over 10 years results, future perspective and training. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) 2017 on HCV and coinfection in Ulaanbaatar, Ulaanbaatar, Mongolia, 2017/06/16
Shiina S. New Local Ablative Therapy for HCC. APASL STC (Asian-Pacific Association for the Study of the Liver, Single Topic Conference) 2017 on HCV and coinfection in Ulaanbaatar, Ulaanbaatar, Mongolia, 2017/06/17
Shiina S. Radiofrequency ablation: TJ experience of over 12,000 treatments in 18 years. The 4th ACTA (Asian Conference on Tumor Ablation) 2017, Canton, China, 2017/11/17
Shiina S. ECIO meets ACTA II: The Asian Experience: Asian ablation: Current status and perspective. The 4th ACTA (Asian Conference on Tumor Ablation) 2017, Canton, China, 2017/11/18
Shiina S. Lusutromboapag in radiofrequency ablation (RFA). The 4th ACTA (Asian Conference on Tumor Ablation) 2017, Canton, China, 2017/11/17-18
Ishii S, Sai JK, Matsumura Y, Suyama M, Fukumura Y, Kanazawa R, Miura H, Sato K, Hayashi M, Shimizu R, Shiina S. A Case of More Than 10-Year Survival of Locally Advanced Unresectable Pancreatic Head Cancer Treated with Chemoradiotherapy. Pancreas 46:837, 2017
Minami T, Tateishi R, Wake T, Nishibatake M, Nakagomi R, Sato M, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Shiina S, Koike K. Hepatocellular carcinoma recurrence after curative treatments in patients with chronic hepatitis C who underwent direct-acting antiviral therapy. HEPATOLOGY, 66:760A-1A, 2017
Tateishi R, Shiina S, Minami T, Wake T, Nishibatake M, Nakagomi R, Fujiwara N, Sato M, Enooku K, Uchino K. Long-term Outcome After Radiofrequency Ablation for Hepatocellular Carcinoma With Special Interest to Anti-viral Therapy. HEPATOLOGY, 66:778A, 2017